Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
5(63%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
13%
Ph not_applicable
1
13%
Ph phase_3
2
25%
Ph phase_2
4
50%

Phase Distribution

1

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 2Efficacy & side effects
4(50.0%)
Phase 3Large-scale testing
2(25.0%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

5

trials recruiting

Total Trials

8

all time

Status Distribution
Active(6)
Completed(1)
Terminated(1)

Detailed Status

Recruiting4
Withdrawn1
Active, not recruiting1
Completed1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
5
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (12.5%)
Phase 24 (50.0%)
Phase 32 (25.0%)
N/A1 (12.5%)

Trials by Status

withdrawn113%
active_not_recruiting113%
recruiting450%
completed113%
not_yet_recruiting113%

Recent Activity

5 active trials
Showing 5 of 8
recruitingphase_3

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

NCT04423211
recruitingphase_2

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

NCT06368817
active_not_recruitingphase_2

Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study

NCT05075980
recruitingphase_2

De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA

NCT05541016
recruitingearly_phase_1

Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer

NCT06914999
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT04423211Phase 3

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Recruiting
NCT06368817Phase 2

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

Recruiting
NCT05075980Phase 2

Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study

Active Not Recruiting
NCT05541016Phase 2

De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA

Recruiting
NCT06914999Early Phase 1

Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer

Recruiting
NCT07215910Phase 3

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

Not Yet Recruiting
NCT04276194Not Applicable

Vertebral Body Sparing Craniospinal Irradiation for Pediatric Patients With Cancer of the Central Nervous System

Completed
NCT04834349Phase 2

Re-irradiation With NBTXR3 in Combination With Pembrolizumab for the Treatment of Inoperable Locoregional Recurrent Head and Neck Squamous Cell Cancer

Withdrawn

All 8 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
8